Protein arginine deiminase 4: a target for an epigenetic cancer therapy
- 13 August 2010
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 68 (4) , 709-720
Abstract
The recent approvals of anticancer therapeutic agents targeting the histone deacetylases and DNA methyltransferases have highlighted the important role that epigenetics plays in human diseases, and suggested that the factors controlling gene expression are novel drug targets. Protein arginine deiminase 4 (PAD4) is one such target because its effects on gene expression parallel those observed for the histone deacetylases. We demonstrated that F- and Cl-amidine, two potent PAD4 inhibitors, display micromolar cytotoxic effects towards several cancerous cell lines (HL-60, MCF7 and HT-29); no effect was observed in noncancerous lines (NIH 3T3 and HL-60 granulocytes). These compounds also induced the differentiation of HL-60 and HT29 cells. Finally, these compounds synergistically potentiated the cell killing effects of doxorubicin. Taken together, these findings suggest PAD4 inhibition as a novel epigenetic approach for the treatment of cancer, and suggest that F- and Cl-amidine are candidate therapeutic agents for this disease.Keywords
This publication has 38 references indexed in Scilit:
- Functional Connection between Deimination and Deacetylation of HistonesMolecular and Cellular Biology, 2009
- Increased PADI4 expression in blood and tissues of patients with malignant tumorsBMC Cancer, 2009
- Mechanism-Based Small Molecule Probes for Labeling CD38 on Live CellsJournal of the American Chemical Society, 2009
- Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formationJournal of Cell Biology, 2009
- Regulation of p53 Target Gene Expression by Peptidylarginine Deiminase 4Molecular and Cellular Biology, 2008
- Histone Arg Modifications and p53 Regulate the Expression of OKL38, a Mediator of ApoptosisJournal of Biological Chemistry, 2008
- An improved synthesis of haloacetamidine-based inactivators of protein arginine deiminase 4 (PAD4)Tetrahedron Letters, 2008
- Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drugNature Biotechnology, 2007
- Activity-Based Protein Profiling Reagents for Protein Arginine Deiminase 4 (PAD4): Synthesis and in vitro Evaluation of a Fluorescently Labeled ProbeJournal of the American Chemical Society, 2006
- Inhibitors and Inactivators of Protein Arginine Deiminase 4: Functional and Structural Characterization,Biochemistry, 2006